MSMichael Springer

Michael Springer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael Springer has a total of 323 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identification and deletion of the extracellular polysaccharide slime pathway across the genus Xanthobacter

    by Maximillian P.M. Soltysiak, Amogh P. Jalihal, Nathan R. Schaumburger, Michael Springer

    Foods and commodities made by microbial bioproduction offer a sustainable alternative to those produced from our traditional petrochemical-based supply chains. Increasingly, Xanthobacter strains are used for bioproduction because of their unique metabolic properties (e.g., CO 2 and N 2 fixation) and wide feedstock range, including growth on agricultural products (e.g., fructose, sucrose) and electrically generated substrates (e.g., hydrogen gas, methanol, acetate, and formate). Many Xanthobacter strains, however, produce an extracellular polysaccharide (EPS) slime that makes plating, pelleting, and handling these cultures challenging and shuttles away resources from biomass and other biosynthetic pathways. While slime-free mutants of slime- producing Xanthobacter strains have been isolated, the causative mutations were unknown. Thus, slime-free mutants need to be painstakingly reisolated based on phenotypic properties in each academically and industrially relevant strain, unless we know the gene to target. Here, we identified the gene and underlying mutation that causes a slime-free phenotype in the X. autotrophicus mutant 7CSF. When we deleted this gene, xsbA , slime production was abolished in the wild-type strain. We showed that deleting xsbA homologs similarly abolished slime production in slime-producers across the genus Xanthobacter ( X. versatilis, X. autotrophicus, X. flavus, and X. tagetidis ). We also identified a Wzx/Wzy-dependent EPS pathway downstream of xsbA that is conserved across slime-producing Xanthobacter strains. Lastly, abolishing slime production improved colony formation and pelleting, with minimal impact on growth. We demonstrated that challenging phenotypic properties in Xanthobacter strains can be removed, improving their usability as a chassis for sustainable bioproduction. Importance: Xanthobacter strains are promising as microbial platforms for bioproduction to more sustainably make our foods and commodities than current petrochemical-based methods. However, many of these strains produce a sugary slime that can make handling these strains difficult and that shuttles resources away from more desirable pathways. While slime-free mutants of Xanthobacter strains have been isolated before, the mutation that caused this change was unknown, and slime-free mutants would need to be reisolated each time. Here, we identify a gene, designated xsbA , that can be deleted in slime-producing Xanthobacter strains to remove their ability to make slime. Strains with the gene deleted become easier to handle and process, with minimal impact on growth. We also discovered additional genes involved in Xanthobacter slime production, which could be used to manipulate and engineer the properties of their slime for useful purposes.

  • Open Access

    Engineered bacterial siderophore production accelerates rock weathering for carbon removal

    by Neil C. Dalvie, Amogh P. Jalihal, Abigail Fitzgibbon, Jan-Tobias Böhnke, Mohammed Hijaz, Quincey A. Justman, Steven J. Davis, Pamela A. Silver, Michael Springer


  • Open Access

    Glucose repression of HXK1 is glucose flux-dependent via non-canonical regulation of Mig1

    by Ang Li, Michael Springer

    Glucose is the preferred carbon source for budding yeast. Glucose sensing is achieved through multiple pathways, and the regulation of glucose-responsive genes has been reported to depend on both glucose concentration and glucose flux. However, the extent to which either of these mechanisms is used, and how cells sense glucose metabolic flux and couple it to transcriptional repression, remains unclear. Using tunable control of hexose transporters and hexokinases together with an optimized intracellular glucose sensor, we decoupled glucose uptake, phosphorylation, and intracellular glucose levels. We found that regulation of a Mig1-dependent reporter gene correlates with glucose flux rather than glucose concentration. Deletion of all known plasma membrane glucose sensors or replacement of yeast hexokinase with a bacterial glucokinase did not disrupt flux-correlated repression. Systematic mutational analysis of glucose signaling pathways showed that this Mig1-dependent response is mediated by the Snf1/AMPK pathway, but only at low glucose concentrations. At high glucose concentrations, Mig1 activity is controlled by an unknown, non-canonical mechanism. While consistent with much of the extensive literature on glucose regulation in S. cerevisiae , this work shows that careful quantitative analysis can uncover previously unrecognized modes of regulation.

  • Open Access

    Using enantioselective biosensors to evolve asymmetric biocatalysts

    by Simon D’OElsnitz, Wantae Kim, Nicole N. Zhao, Haley Hardtke, Svetlana P. Ikonomova, Nina Alperovich, Olga Vasilyeva, Michael J. James, Eric S. Zigon, Michael B. Cory, et al.


  • Open Access

    Development and validation of a multiplexed quantitative PCR assay for clinical detection and surveillance of Oropouche virus

    by Elyse Stachler, Kyle McMahon, Nisha Gopal, Hannah Knoll, Keith R. Baillargeon, Andrea C. Mora, Hunter A. Wondrash, Evan M. Sullivan, Sarah Rush, Dawn Gratalo, et al.

    Background: Oropouche virus (OROV) is an emerging vector-borne virus with rapidly expanding geographic range, increasing case counts, and growing evidence of severe outcomes including neuroinvasive disease and vertical transmission. Because OROV infection presents with nonspecific febrile illness that overlaps clinically with other viruses including dengue, zika, and chikungunya, accurate molecular diagnostics are essential for patient care and surveillance. Yet existing assays rely on single genomic targets and are vulnerable to detection failure as the virus evolves and reassorts. Methodology/Principal Findings: To support diagnostic capacity, we developed and clinically validated a multiplexed qPCR assay targeting three regions of the OROV S segment, incorporating redundancy to preserve sensitivity across viral diversity while enabling robust clinical interpretation. The multiplex also includes an assay targeting RNaseP as an internal sample control to ensure adequate sample processing. We evaluated assay performance using both historical and contemporary OROV strains and validated the assay on contrived serum, plasma, and cerebrospinal fluid samples, assessing linearity, limit of detection (LOD), accuracy, specificity, precision, and sample stability. The assay met or exceeded all predefined acceptance criteria for clinical testing and achieved an LOD as low as 6 copies per reaction for contemporary outbreak strains. We further implemented a logic-based interpretation matrix that reduced false-positive risk while maintaining sensitivity near the analytical LOD. Conclusions/Significance: Our assay sensitively and specifically detects OROV RNA in serum, plasma, and cerebrospinal fluid while incorporating safeguards against viral evolution and reassortment. The assay has been approved for use by CLIA at Nexus Medical Labs in 49 U.S. states, expanding access to timely OROV diagnostics in the United States and providing a durable framework for molecular detection of reassorting, rapidly evolving viruses as OROV continues to spread into new regions. Author Summary: We present a fully validated multiplex qPCR assay for detection of Oropouche virus (OROV) in clinical samples. Our multiplex design includes three assays targeting distinct regions of the S segment, protecting against assay failure due to mutation dropout. In addition, we include a human internal control assay (RnaseP), which gives confidence to pathogen-negative clinical results by ensuring sample quality and adequate sample processing. The assay exhibits high sensitivity and specificity, and can be adopted by other labs should expanded OROV surveillance be needed. With geographic and case number expansion of OROV in recent years, this assay adds to the available tools for surveillance and clinical diagnosis, mitigating negative effects of the virus in the future.

  • Open Access

    Ligify 2.0: a web server for predicted small molecule biosensors

    by Simon D'OElsnitz, Nicole N Zhao, Pranay Talla, Jio Jeong, Joshua D Love, Michael Springer, Pamela A Silver

    Prokaryotic transcription factors (TFs) serve as small molecule biosensors with broad applications in biotechnology, yet only a fraction have been characterized. To address this gap, we recently described the bioinformatic method Ligify, which leverages information from genome context and enzyme reaction databases to predict a TF’s cognate effector molecule. Here, we report Ligify 2.0, a modern web server for Ligify predictions. We systematically evaluate 10 965 small molecules within the Rhea enzyme reaction database for associations to TFs, ultimately generating 13 435 hypothetical interactions between 1 362 small molecules and 3 164 TFs. We then develop an interactive web server (https://ligify.groov.bio) to search and visualize prediction data. Each TF sensor page includes visualizations for chemical ligand structures, interactive TF protein structures, and genome context. Pages also include metadata links, predicted promoter sequences, prediction confidence metrics, and references to relevant literature. A plasmid builder tool enables users to generate custom biosensor circuit designs. Finally, we provide case studies using Ligify 2.0 to identify two TFs from the pathogens Escherichia coli O157:H7 and Mycobacterium abscessus responsive to 4-hydroxybenzoate and Pseudomonas Quinolone Signal, respectively. The Ligify web server aims to facilitate the systematic characterization of biosensors for chemical-control of biological systems.


  • Open Access

    groovDB in 2026: a community-editable database of small molecule biosensors

    by Joshua D Love, Brady M Rafferty, Michael Thomas, Nicole N Zhao, Pranay Talla, Michael Springer, Pamela A Silver, Simon D’oElsnitz

    The groovDB database (https://groov.bio) was launched in 2022 with the goal of organizing information on prokaryotic ligand-inducible transcription factors (TFs). This class of proteins is important in fundamental areas of microbiology research and for biotechnological applications that develop biosensors for diagnostics, enzyme screening, and real-time metabolite tracking. Uniquely, groovDB contains stringently curated, literature-referenced data on both TF:DNA and TF:ligand interactions. Here, we describe a major technical update to groovDB, making the database community-editable and adding several advanced features. Users can now add new TF entries and update existing entries using a simple online form. New user interface elements display interactive protein structures and DNA-binding motifs. Updated query methods enable database searches via text, chemical similarity, and attribute filtering. A new data architecture reduces page load time by five-fold. Finally, the number of TF entries has more than doubled and all source code is now open-access.


  • Open Access

    Ligify 2.0: A web server for predicted small molecule biosensors

    by Simon D'OElsnitz, Nicole N Zhao, Pranay Talla, Jio Jeong, Joshua David Love, Michael Springer, Pamela A. Silver

    Prokaryotic transcription factors (TFs) are used as small molecule biosensors with broad applications in biotechnology, yet only a small fraction from microbial genomes have been characterized. To address this gap, we recently described the bioinformatic method Ligify, which leverages information from genome context and enzyme reaction databases to predict a TFs cognate effector molecule. Here we report Ligify 2.0, a modern web server for Ligify predictions. We systematically evaluate 10,965 small molecules within the Rhea enzyme reaction database for associations to TFs, ultimately generating 13,435 hypothetical interactions between 1,362 small molecules and 3,164 TFs. We then develop an interactive web server (https://ligify.groov.bio) to search and visualize prediction data. Each TF sensor page includes visualizations for chemical ligand structures, interactive TF protein structures, and genome context. Pages also include metadata links, predicted promoter sequences, prediction confidence metrics, and references to relevant literature. A plasmid builder tool enables users to generate custom biosensor circuit designs. Finally, we provide case studies using Ligify 2.0 to identify two TFs from the pathogens Escherichia coli O157:H7 and Mycobacterium abscessus responsive to 4-hydroxybenzoate and Pseudomonas Quinolone Signal, respectively. The Ligify web server aims to facilitate the systematic characterization of biosensors for chemical-control of biological systems.

  • Expansion and revision of the genus Xanthobacter and proposal of Roseixanthobacter gen. nov.

    by Maximillian P. M. Soltysiak, Amogh P. Jalihal, Caroline E. Christophersen, Audrey L. H. Ory, Andrew D. Lee, Jessica Boulton, Michael Springer

    The nitrogen-fixing, chemolithoautotrophic genus Xanthobacter is found across numerous diverse environments worldwide and is an important member of many ecosystems. These species serve as model systems for their metabolic properties and have industrial applications in bioremediation and sustainable protein, food and fertilizer production. Despite their abundance and utility, the majority of Xanthobacter strains are without a genome sequence, and only eight validly published species are known to date. To expand our understanding of the diversity and evolutionary history of the genus, we sequenced the genomes of 37 repository strains and 26 novel environmental strains we isolated. After performing comparative phylogenomic analyses, we expand and revise the genus Xanthobacter and propose the novel genus Roseixanthobacter gen. nov. For Xanthobacter, we describe 9 novel species (bringing the total to 17): Xanthobacter albus sp. nov. (V0C-6T=DSM 117699T=ATCC TSD-450T), Xanthobacter cornucopiae sp. nov. (V4C-4T=DSM 117704T=ATCC TSD-451T), Xanthobacter lutulentifluminis sp. nov. (V3C-3T=DSM 117706T=ATCC TSD-452T), Xanthobacter nonsaccharivorans sp. nov. (14gT=DSM 431T=JCM 1201T=CIP 105432T=NCIMB 10811T), Xanthobacter pseudotagetidis sp. nov. (KAT=DSM 11602T=KCTC 8467T), Xanthobacter sediminis sp. nov. (V8C-5T=DSM 117708T=ATCC TSD-453T), Xanthobacter variabilis sp. nov. (V4C-8T=DSM 117713T=ATCC TSD-454T), Xanthobacter versatilis sp. nov. (Py2T=DSM 118458T=ATCC BAA-1158T) and Xanthobacter wiegelii sp. nov. (RH 10T=DSM 597T=JCM 7864T=CIP 105437T). For Roseixanthobacter gen. nov., we describe five novel species formerly classified as Xanthobacter: Roseixanthobacter finlandensis sp. nov. (VTT E-85241T=BIO GISA 20T=DSM 117884T), Roseixanthobacter glucoisosaccharinicivorans sp. nov. (VTT E-85242T=BIO GISA 21T=DSM 117885T), Roseixanthobacter liquoris sp. nov. (VTT E-85238T=BIO GISA 16T=DSM 117882T), Roseixanthobacter pseudopolyaromaticivorans sp. nov. (VTT E-85240T=BIO GISA 19T=DSM 117883T) and Roseixanthobacter psychrophilus sp. nov. (W30T=DSM 24535T=KCTC 8466T). We characterized the phenotypic properties of these type strains, including temperature, salinity and pH ranges, carbon substrate utilization, motility, slime production, autotrophic growth and enzymatic activities. We discovered a more diverse range of phenotypes across the genus Xanthobacter than previously known and elucidated the evolutionary history within the genus. These findings and genome sequences will help further the application of Xanthobacter biology in academic, industrial and environmental settings and provide additional insight into the unique biological properties that make these species attractive for such applications.


  • Open Access

    groovDB in 2025: A community-editable database of small molecule biosensors

    by Joshua David Love, Brady Michael Rafferty, Michael Thomas, Nicole N Zhao, Pranay Talla, Michael Springer, Pamela A. Silver, Simon D'Oelsnitz

    The groovDB database (https://groov.bio) was launched in 2022 with the goal of organizing information on prokaryotic ligand-inducible transcription factors (TFs). This class of proteins is important in fundamental areas of microbiology research and for biotechnological applications that develop biosensors for diagnostics, enzyme screening, and real-time metabolite tracking. Uniquely, groovDB contains stringently curated, literature-referenced data on both TF:DNA and TF:ligand interactions. Here, we describe a major technical update to groovDB, making the database community-editable and adding several advanced features. Users can now add new TF entries and update existing entries using a simple online form. New user interface elements display interactive protein structures and DNA-binding motifs. Updated query methods enable database searches via text, chemical similarity, and attribute-filtering. A new data architecture reduces page load time by five-fold. Finally, the number of TF entries has more than doubled and all source code is now open-access.